by Eric Valois | Sep 14, 2020 | Uncategorized
Jesta Group is a proud investor in cResponse, an innovative cancer treatment technology designed by Curesponse in collaboration with the Weizmann Institute of Science, in order to provide a more personalized and efficient treatment of the disease. cResponse takes a...
